NCT05322512View on ClinicalTrials.gov

Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 1, 2024

Study Completion Date

December 31, 2025

Conditions
Solid Tumor
Interventions
DRUG

18F-FDG

All enrolled participants will be allocated to undergo one 18F-FDG PET/CT scan.

All Listed Sponsors
lead

Peking University Cancer Hospital & Institute

OTHER

NCT05322512 - Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors | Biotech Hunter | Biotech Hunter